Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2209–2232 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Schizophrenia, Schizophrenia and Related Disorders, Bipolar Disorder, Bipolar and Related Disorders, Major Depressive Disorder, Major Depression Severe, Ketogenic Dieting, Ketosis, Metabolic Disease, Metabolic Syndrome
Interventions: LCHF Ketogenic Diet, Diet-as-Usual (DAU); Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Aging
Interventions: Low dose ASA, Control; Drug · Other
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Lynch Syndrome
Interventions: Electronic Consent (iPad); Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 703 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Rapid Atrial Fibrillation, Heart Rate Control
Interventions: Dexmedetomidine Hydrochloride, Normal Saline; Drug · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Peripheral Arterial Disease, Painful Diabetic Neuropathy, Diabetes Mellitus, Type 2, Chronic Pain, Spinal Cord Stimulation, Chronic Pain Syndrome, Limb Pain
Interventions: Spinal cord stimulation, Sham stimulation; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 89 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obesity, Obesity, Abdominal, Metabolic Syndrome, Weight Loss
Interventions: Vestibular nerve stimulator, Sham vestibular stimulation; Device
Lead sponsor: Neurovalens Ltd.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: San Diego, California

Conditions: Restless Legs Syndrome
Interventions: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml, Normal saline - 1ml; Drug
Lead sponsor: Lowcountry Infectious Diseases; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Integrated Care, Standard Therapy; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years and older
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Aortic Aneurysm, Aortic Disease
Interventions: clevidipine.; Drug
Lead sponsor: Asma Zainab, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Metastatic Melanoma
Interventions: Allovectin-7®, Dacarbazine (DTIC), Temozolomide (TMZ); Biological · Drug
Lead sponsor: Vical; Industry
Eligibility: 18 Years and older
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 27
States / cities: Tucson, Arizona • Little Rock, Arkansas • Bakersfield, California + 21 more

Conditions: Obesity
Interventions: Obalon Intragastric Balloons, Sham Device, Nutrition and Lifestyle Program; Device · Behavioral
Lead sponsor: Obalon Therapeutics, Inc.; Industry
Eligibility: 22 Years to 64 Years
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 15
States / cities: Scottsdale, Arizona • Anaheim, California • Coronado, California + 12 more

Conditions: Constipation, Fecal Incontinence in Children, Pelvic Floor Dyssynergia
Interventions: Posterior Tibial Nerve Stimulation (PTNS), Sham Stimulation; Device
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 8 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Overactive Bladder (OAB), Urinary Urgency, Urinary Urge Incontinence (UUI), Nocturia, Urinary Frequency
Interventions: RiSolve App, AUGS Patient Handouts; Device · Behavioral
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 22 Years and older · Female only
Enrollment: 596 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 10
States / cities: Birmingham, Alabama • Palo Alto, California • Washington D.C., District of Columbia + 7 more

Conditions: Vaginal Personal Care
Interventions: VM-02, Commercial Oral Probiotic Competitor, VM-02 Placebo; Other · Dietary Supplement
Lead sponsor: Seed Health; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Venice, California

Conditions: Back Pain Lower Back Chronic
Interventions: Placebo, Hydrocodone bitartrate; Drug
Lead sponsor: Zogenix, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 51
States / cities: Phoenix, Arizona • Jonesboro, Arkansas • Anaheim, California + 47 more

Conditions: Gestational Diabetes, Type2 Diabetes
Interventions: DPP only, Diabetes Prevention Program (DPP) online + doula divas; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Child Obesity
Interventions: The Teacher Education and Classroom Habits (T.E.A.C.H.) Program; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Alcohol Abuse
Interventions: Nutrition time control/placebo intervention, Computer-delivered, brief intervention on alcohol use; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Uncomplicated Pregnancy, Abnormal Fetal Growth or Fluid
Interventions: Clinically-indicated ultrasound, Serial third trimester ultrasound; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Bellaire, Texas • Houston, Texas

Conditions: Nicotine Dependence
Interventions: Quit Line plus MTS, Quit Line Only; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Pain
Interventions: Lidocaine injection, Gyldo, Saline; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Bay Shore, New York • Huntington, New York • Smithtown, New York

Conditions: Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium, Thinning Hair, Hair Loss/Baldness, Hair Thinning
Interventions: ALRV5XR, ALRV5XR Shampoo, ALRV5XR Conditioner, ALRV5XR Hair Follicle Serum (Nutriment), Placebo, Placebo Shampoo, Placebo Conditioner, Placebo Hair Follicle Serum (Nutriment); Dietary Supplement · Other
Lead sponsor: Arbor Life Labs; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Nicotine Dependence
Interventions: Varenicline, Placebo, Smoking Cessation Counseling; Drug · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Presbyopia
Interventions: Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine Ophthalmic Topical Cream, Dose 2, Pilocarpine Ophthalmic Topical Cream, Dose 3, Placebo Ophthalmic Topical Cream; Drug
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 40 Years to 55 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 10
States / cities: Chandler, Arizona • Sun City, Arizona • Glendale, California + 7 more

Search by objective public record fields.

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

Identification of Critical Thermal Environments for Aged Adults

Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants

Controlling Rapid Atrial Fibrillation With Dexmedetomidine

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

Vestibular Stimulation to Trigger Adipose Loss Clinical Trial

Neuroma Injections to Treat Restless Legs Syndrome - RCT

Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado

A Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT)

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Obalon Balloon System Pivotal IDE (SMART) Trial

Posterior Tibial Nerve Stimulation for Children With Pelvic Floor Dyssynergia

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

Randomized, Double-blind, Placebo-controlled Trial Investigating the Role of a Personal Care Product on Vaginal Health

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention

Development and Evaluation of the T.E.A.C.H. Study: A Randomized Control Trial

Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy

Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial

Trial on the Effectiveness of Mindfulness Training for Smokers

This Study is Comparing Pain Outcomes After Urethral Bulking When Participants Are Randomized to Two Different Pain Medication Regimens.

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss

Varenicline for Nicotine Dependence Among Those With HIV/AIDS

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia